miglitol   Click here for help

GtoPdb Ligand ID: 4842

Synonyms: Glyset® | N-hydroxylethyl-1-deoxynojirimycin
Approved drug PDB Ligand
miglitol is an approved drug (FDA (1996))
Compound class: Synthetic organic
Comment: Miglitol is an iminosugar type drug which inhibits alpha-glucosidase as a mechanism to improve glycemic control in type II diabetics.
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: miglitol

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 5
Rotatable bonds 3
Topological polar surface area 104.39
Molecular weight 207.11
XLogP -2.26
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OCCN1CC(O)C(C(C1CO)O)O
Isomeric SMILES OCCN1C[C@H](O)[C@H]([C@@H]([C@H]1CO)O)O
InChI InChI=1S/C8H17NO5/c10-2-1-9-3-6(12)8(14)7(13)5(9)4-11/h5-8,10-14H,1-4H2/t5-,6+,7-,8-/m1/s1
InChI Key IBAQFPQHRJAVAV-ULAWRXDQSA-N
No information available.
Summary of Clinical Use Click here for help
Used to improve glycemic control in type 2 diabetes patients.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Miglitol inhibits membrane-bound intestinal alpha-glucoside hydrolase enzymes. These enzymes have the function of hydrolysing oligosaccharides and disaccharides to glucose and other monosaccharides. therefore their inhibition leads to delayed glucose absorption and lowering of postprandial hyperglycemia.